drugset / Trial / NCT00740142

Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy

NCT00740142

Phase 4 Completed 35 enrolled Mahidol University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Hypothesis: Is the combination of oral L-ornithine-L-aspartate and lactulose more efficacious than oral lactulose alone in treatment of hepatic encephalopathy? Study design; Randomized, double-blinded, placebo controlled trial

Timeline

Start
2008-09
Primary completion
2010-08
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator L-ornithine L-aspartate Other / unclassified 3 g Oral
Comparator Lactulose Other / unclassified Oral